Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...
A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. Investigator sites are essential for ...
For millions of asthma sufferers worldwide, the distinctive puff of an inhaler represents a lifeline, providing instant relief from constricted airways. Dr Juma Bwika, a pulmonologist at Aga Khan ...
Topline results were announced from a phase 3b trial evaluating albuterol/budesonide metered dose inhaler in ... (ICS) asthma rescue therapy approved under the brand name Airsupra ...
A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after the drug outperformed a standard therapy. The phase 3b BATURA study showed Airsupra ...
Doctors recommend using either a rescue inhaler or nebulizer during an asthma attack. But while the first priority is to open the airways, frequent use of rescue meds could mean you and your ...
On the other hand, if your inhaler is only for occasional or rescue use, like during an asthma attack, it might expire before you use up all the metered puffs. Inhalers don't have chemicals that ...
Those using a rescue inhaler during an asthma attack, especially, may want a propellant to help push the medicine into their airways. This is why GSK Plc is focusing on lowering the emissions of ...